Skip to content

The Effect of Sihogayonggolmoryeo-tang on the Anxiety of Hwa-byung

Phase 4 Study of The Effect of Sihogayonggolmoryeo-tang on the Anxiety of Hwa-byung : A Randomized, Double Blind, Placebo-control Trial

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01362114
Enrollment
160
Registered
2011-05-27
Start date
2010-07-31
Completion date
2012-06-30
Last updated
2012-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hwa-byung

Keywords

Hwa-byung, Sihogayonggolmoryeo-tang, Anxiety

Brief summary

In this randomized, double blinded, Placebo-control Trial, the investigators planned to give Sihogayonggolmoryeo-tang extract or controlled medication on the Anxiety of Hwa-byung.

Interventions

DRUGSIHOGAYONGGOLMORYU TANG EXTRACT GRAN

three times a day, AC 30 min., 4 capsules taken each time (4capsules=2.5g), 8 weeks

OTHERPlacebo

three times a day, AC 30 min., 4 capsules taken each time (4capsules=2.5g), 8 weeks.

Sponsors

Korea Health Industry Development Institute
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* male or female aged 20-65 * subjects who meet structured interview criteria for Hwa-Byung Diagnosis * subjects who have axiety (more than 17 score in HAMA)

Exclusion criteria

* duration of illness less than 6 months * current or past history of delusions, hallucination * past history of at least one manic episode, hypomanic episode, or mixed episode * current or past history of alcohol abuse or alcohol dependence history * taking substances(e.g. steroids) which might affect symptoms * medical conditions(e.g. hyperthyroidism, hypothyroidism, heart disease) that might affect symptoms * current with hepatoma, hepatic cirrhosis, chronic renal failure, congestive heart failure * pregnancy, lactation, women not using medically accepted means of birth control * considered not apt to carry out clinical trial

Design outcomes

Primary

MeasureTime frameDescription
Hamilton Anxiety Scale(HAM-A)8 weeksThe HAM-A (Hamilton Anxiety Scale) is a widely used interview scale that measures the severity of a patient's anxiety, based on 14 parameters, including anxious mood, tension, fears, insomnia, somatic complaints and behavior at the interview.

Secondary

MeasureTime frameDescription
Beck Depression Inventory(BDI)8 weeksBDI is a 21-question multiple-choice self-report inventory, one of the most widely used instruments for measuring the severity of depression. Each question has a set of at least four possible answer choices, ranging in intensity. When the test is scored, a value of 0 to 3 is assigned for each answer and then the total score is compared to a key to determine the depression's severity.
WHO Quality of Life Abbreviated(WHOQOL-BREF)8 weeksQuality of life is used to evaluate the general well-being of individuals and societies.
Heart Rate Variability(HRV)8 weeksHeart rate variability (HRV) is a physiological phenomenon where the time interval between heart beats varies. It is measured by the variation in the beat-to-beat interval.
likert scale8 weeksThis scale is used to evaluate the degree of Hwa-byung's major symptom by 5 point measure. (0,1,2,3,4)
State-Trait Anxiety Inventory(STAI)8 weeksThe State-Trait Anxiety Inventory (STAI) was initially conceptualized as a research instrument for the study of anxiety in adults. It is a self-report assessment device which includes separate measures of state and trait anxiety.
State-Trait Anger Expression Inventory (STAXI)8 weeksThe State-Trait Anger Expression Inventory is a inventory which measures the intensity of anger as an emotional state (State Anger) and the disposition to experience angry feelings as a personality trait (Trait Anger). Items consist of 4-point scales that assess intensity of anger at a particular moment and the frequency of anger experience, expression, and control.
Insomnia Severity Index (ISI)8 weeksThe Insomnia Severity Index is a series of questions, seven in total, designed by medical professionals to help gauge the seriousness of a person's insomnia. The seven questions have numerical value, and the total is added up at the end of the process to give a total that symbolizes the seriousness of the problem
Instrument of Oriental Medical Evaluation for Hwa-Byung8 weeksInstrument of Oriental Medical Evaluation for Hwa-Byung is a standard scale to evaluate for Oriental Medical cure in Hwa-Byung
Hwa-byung scale8 weeksThis scale is used for self report to evaluate the Hwa-byung's emotional symptoms, physical symptoms and personality traits by 5 point.(0,1,2,3,4).

Countries

South Korea

Contacts

Primary ContactBOK NAM SEO
florence73@hanmail.net

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026